key: cord-0828457-idlwrkm7
authors: Martinelli, Federico; Perrone, Anna; Della Noce, Isabella; Colombo, Lorenzo; Lo Priore, Stefano; Romano, Simone
title: Application of a portable instrument for rapid and reliable detection of SARS‐CoV‐2 infection in any environment
date: 2020-04-23
journal: Immunol Rev
DOI: 10.1111/imr.12857
sha: ff67fae27f179d5d8f162649edad462ebef87a8d
doc_id: 828457
cord_uid: idlwrkm7

The ongoing outbreak of the novel coronavirus (SARS‐CoV‐2) infection is creating serious challenges for health laboratories that seek to identify viral infections as early as possible, optimally at the earliest appearance of symptom. Indeed, there is urgent need to develop and deploy robust diagnostic methodologies not only to use in health laboratory environments but also directly in places where humans circulate and spread the virus such as airports, trains, boats, and any public aggregation places. The success of a reliable and sensitive asymptomatic diagnosis relies on the identification and measurement of informative biomarkers from human host and virus in a rapid, sensitive, and inexpensive manner. The objective of this article is to describe an innovative multidisciplinary approach to develop an efficient, inexpensive, and easy‐to‐use portable instrument (bCUBE(®) by Hyris Ltd) that can be employed as a surveillance system for the emergency caused by SARS‐CoV‐2. A solution for Coronavirus testing, compliant with CDC guidelines, is scheduled to be released in the next weeks. In addition, we will describe a workflow and path of an integrated multi‐omic approach that will lead to host and pathogen biomarker discovery in order to train the instrument to provide reliable results based on a specific biomarker's fingerprint of SARS‐CoV‐2 infection.

A workflow of the coronavirus primary screening has been shown in Figure 1 . A reliable diagnosis of the viral infection is one the most urgent priorities for public health management of the disease spread. Usually in acute respiratory infection, RT-PCR is traditionally employed to identify viruses in respiratory secretions. A robust detection technology is usually based on real-time RT-PCR because it is highly sensitive and specific, although it requires infrastructure, skilled personnel and at least 4-6 hours for analysis. Currently available techniques do not provide results before several hours or even days, and the tests require a well-equipped laboratory and trained personnel. Indeed, these methods are not efficient to rapidly screen a high number of individuals in places where thousands of people transit per hours. These methods are effective in confirming the infections when symptoms are already present but they are completely inefficient to identify infections at asymptomatic stage. The development of a means for a quick and simple detection of this virus in humans is a worldwide priority considering that infections have been observed in world areas such as Africa where the scarce health assistance will not be able to control the spread. Indeed, it is important to generate new ideas that will allow the development of new detection prototypes able to quickly identify infected humans and prevent the virus from spreading.

A large number of possible host-pathogen biomarkers (transcripts, miRNAs, proteins, metabolites) may be analyzed through different omic tools. Here, we propose the application of a portable instrument based on the analysis of molecular responses at transcript level. The proposed approach consists in the adaptation of an existing infield portable technology currently used for real-time detection of viral agents in plants, for detection of SARS-CoV-2 in for destruction of SARS-CoV-2 before irreversible negative effects on human health has occurred (these approaches may focus on targeting of human immune system); and (c) identification of pathways and bioactive compounds that can stimulate the innate immune responses. Indeed, the proposed approach is to identify and analyze biomarkers modulated in either host or pathogen at early stages of infection. When any eukaryotic host is subjected to stress, an "induced stress response" occurs similarly to the host "inflammatory response" to pathogen-associated and pathogen-induced virulence factors. 5 If the induced stress response is enhanced, tissue injury can happen, causing to irreversible effects at asymptomatic stages, because it is often too late to avoid tissue and organ damages once symptoms appear. During the early stages of this condition, the induction of immune stress-related genes and pathways commonly associated with pathogen infection and physiological disorders occur and these genes are typically associated with general early state of stress response. Other differentially regulated genes at the presymptomatic stage are stress specific and may work as useful biomarkers for the early diagnosis of the host health conditions. These responses include changes in the key metabolic pathways associated with key indicators of early stages of infection of known pathogens. Usually, this stress condition usually anticipates the manifestation of symptoms associated with diseases. For this reason, a focus on the analysis of key genes, transcripts, proteins, metabolites, or pathways could be used to monitor the human health status. These induced biological molecules may be used as biomarkers for both stress identification and recovery. The identification of molecules that are early host responses associated in a reversible stress status using portable instruments is the first stage for asymptomatic diagnosis. The biomarker's identification needs the analysis of large data sets through web-based applications that queries large public databases of information on transcripts, proteins, or metabolites modulated in specific biological conditions (ie, Genevestigator).

Here, we propose the employment of an instrument that is already widely used for plant pathogens 6,7 and could be easily adapted also for the detection of SARS-CoV-2. The idea is to use a porta- no host genes strictly specific for a specific pathogen. However, a pool of responsive host genes might be employed as host biomarkers to quickly identify early alarm stress state, better than aspecific methods currently used such the measurement of body temperature for fever detection. A biomarker can be defined as a biological characteristic that can be analyzed and considered as an indicator of a particular physiological such as pathogenic processes, or responses to a therapeutic intervention. In omic sciences, a "biomarker profile" includes a series of transcriptomic, proteomic, and/or metabolomic features linked with a particular stress, development of physiological condition. Combined, these characteristics could become a biomarker of pathogenic condition assisting in diagnosis and therapy. A systems-based approach could gain insight into underlying biological regulatory network (BRN) governing interactions between hosts and pathogens. Heterogeneous omic data sets could be integrated to define a biological regulatory network underlying early host and pathogen biomarkers for asymptomatic detection of the viral infections. To assist the biomarkers discovery, the vast amount of transcriptomic data available in public databases in response to human coronaviruses will allow a deep meta-analysis using previously customized bioinformatics pipelines Ref. [8] [9] [10] [11] . This work consists of re-analyzing raw data obtained by independent experiments using a normalization and standardization procedure included in a bioinformatics pipeline. This work will provide differentially regulated genes from each study finding commonalities and differences in genes,

Proteomics may be also used to validate the discovery of transcriptional markers analyzing the same infection stages considered at transcript level. A possible technique could be the isobaric Tags for Relative and Absolute Quantitation (iTRAQ), typically employed in quantitative proteomics using tandem mass spectrometry to analyze quantitative measurements of protein amount from different sources in a single experiment. Briefly, once proteins are extracted from the same collected tissues (nostril tissues), they may be precipitated using ProteoExtractTM Protein Precipitation kit (Calbiochem), dehydrated, resuspended, and digested with tripsin and generated peptides analyzed using a system composed by QExactive mass spectrometer, an Easy-LC and a nanospray ionization source. Data could be acquired using a data-dependent ms/ms method and raw data should be analyzed using X!Tandem, visualized using Scaffold dk/servi ces/NetNg lyc/). This approach has been successful to determine more than 4500 proteins in plants including both host and pathogen. 7 Considering the systemic presence of SARS-CoV-2, the identification of specific genes from peripheral blood and different tissues would be very helpful to discover tissue-specific host biomarkers. The viral infection is typically perceived by the host before that the viral nucleic acid can be detected by traditional methods such as quantitative real-time PCR.

Here, we propose the use of the portable device such as bCUBE®2.0 (developed by Hyris Ltd).

The device is a miniaturized device that is able to perform both temperature cycles and isothermal analysis, enabling a wide array of nucleic acid detection methods such as qPCR and isothermal ampli- Gene expression could be conducted collecting samples from human nostrils with tools such as cotton swabs. Confirmation may be performed blood samples. RNA may be extracted from these collection instruments with a quick procedure using simplified extraction procedures.

The typical workflow for the use of the instrument for pathogen detection is shown in Figure 4 . Results may be provided in approximately 2 hours. At the moment, the developed software and hardware are used to target the pathogen DNA, but a next step could F I G U R E 2 Components of Hyris platform: bCUBE ® , bAPP, bKit, and starter kit F I G U R E 3 Additional details of the components of the portable system be the analysis of host Xf-regulated genes discovered by meta-analysis works. Implementation and validation tests of the results obtained directly by the portable device could be conducted analyzing the same tissues with traditional laboratory equipment. This work would verify the consistency of the field results delivered by the instrument.

The proposed instrument fits well when a quick, easy, reliable and inhouse early detection (and confirmation) is required to rapidly decontaminate environments and initiate quarantine of infected individuals.

The workflow for a secondary coronavirus screening using bCUBE ® is F I G U R E 4 Typical workflow for the use of bCUBE ® for detection of pathogens from DANN extraction to results readout F I G U R E 5 Possible workflow of Coronavirus secondary screening using bCUBE ® portable instrument shown in Figure 5 . The system is able to detect not only viruses, but also specific bacteria, proteins, and DNA molecules, an increased or reduced concentration of which in a person's saliva, blood and other tissues (ie, nostrils) provide the diagnosis of the SARS-CoV-2 infections.

The most important aspect of this tool is the extreme ease of use and the automatic interpretation of the results. The app has an intuitive interface and can guide the operator through every step of the setup and analysis. Initiation in the analysis is simple and the automatic result interpretation engine can assist the operator in determining the outcome.

The supplied power source works at both 110 V and 220 V, and the power cord can be easily interchanged with the one compatible with the standard of your destination country. Real-time and remote control of the bCUBEs is allowed thanks to the connection to Hyris bDATA ® service. The instrument is well suitable to work on boats and other quarantine environments for the possibility to have results in short time. It also fits well in the airports after a quick scan of other symptoms (ie, fever) in order to confirm the presence of the viral infections.

We certify that Lorenzo Colombo, Stefano Lo Priore, Isabella Della Noce and Simone Romano are employees of Hyris Ltd. that produces the bCUBE® instrument described in this article.

https://orcid.org/0000-0002-8502-767X

A novel coronavirus outbreak of global health concern

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Potential inhibitors for SARS-CoV-2 coronavirus M protease from clinically approved medicines

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Analysis of early host responses for asymptomatic disease detection and management of specialty crops

Infield and early detection of Xylella fastidiosa infections in olive using a portable instrument

Proteomic analysis highlights the role of detoxification pathways in increased tolerance to Huanglongbing disease

Transcriptomic responses to biotic stresses in Malus x domestica: a meta-analysis study

Identifying host molecular features strongly linked with responses to Huanglongbing disease in citrus leaves

Gaining insight into exclusive and common transcriptomic features linked with biotic stress responses in Malus

Identification of key genes and its chromosome regions linked to drought responses in leaves across different crops thorugh meta-analysis of RNA-seq data

Proposal of a citrus translational genomic approach for early and infield detection of Flavescence dorée in Vitis

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Structural basis of SARS-CoV-2 3Cpro and Anti-COVID-19

Preliminary identification of potential vaccine targets for SARS-CoV-2 based on SARS-CoV immunological studies

The novel coronavirus 2019 (SARS-CoV-2) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including SARS-CoV-2

T cell responses to whole SARS coronavirus in humans

Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection

Preliminary identification of potential vaccine targets for SARS-CoV-2 based on SARS-CoV immunological studies

Characterization of SARS-CoVspecific memory T cells from recovered individuals 4 years after infection

Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment